Iasis Healthcare LLC: Pharmaceuticals and Healthcare Company Profile & SWOT ReportiCD ResearchFebruary 5, 2012 15 Pages - SKU: ICDR6793512 |
| Synopsis ICD Research's Iasis Healthcare LLC: Pharmaceuticals and Healthcare Company Profile & SWOT Report contains in depth information and data about the company and its operations. The profile contains a company overview, business description, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries. Summary ICD Research's Iasis Healthcare LLC: Pharmaceuticals and Healthcare Company Profile & SWOT Report is a crucial resource for industry executives and anyone looking to access key information about Iasis Healthcare LLC. ICD Research's Iasis Healthcare LLC: Pharmaceuticals and Healthcare Company Profile & SWOT Report report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Scope
Iasis Healthcare LLC (Iasis) is a leading owner and operator of community-focused hospitals in high-growth markets in the US. As of May 2011, the company owns and manages 18 acute care hospitals and one behavioral health hospital facility with a total of 4,362 licensed beds. Its hospital facilities are strategically located in seven regions: Salt Lake City, Utah; Phoenix, Arizona; Tampa-St. Petersburg, Florida; five cities in Texas, including Houston and San Antonio; Las Vegas, Nevada; and West Monroe, Louisiana and Woodland Park, Colorado. Iasis also owns and operates Health Choice Arizona, Inc., a Medicaid and Medicare managed health plan in Phoenix that serves more than 197,000 members. Iasis is headquartered in Tennessee, the US. |
Related Markets
Pharmaceuticals Company Reports
- Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2012
- Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
- Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics
- Partnerships, Licensing, Investments and M&A Deals and Trends for March 2012 in Pharmaceuticals
- Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs

